Why you should read this article:

•

To refresh your knowledge of epilepsy, its classification and its higher prevalence in people with learning disabilities

•

To enhance your understanding of the treatment of status epilepticus by carers in the community

•

To count towards revalidation as part of your 35 hours of CPD, or you may wish to write a reflective account (UK readers)

•

To contribute towards your professional development and local registration renewal requirements (non-UK readers)

Status epilepticus (SE) is a complication of epilepsy characterised by prolonged or repeated seizures. It is a life-threatening condition that requires the immediate administration of a rescue medicine. If given promptly, rescue medicines can reduce the duration of seizures and support SE cessation. Buccal midazolam is the recommended first-line treatment for SE in the community in people who have had a previous episode of prolonged or serial convulsive seizures. Therefore, it is crucial that all those who care for people with learning disabilities who have epilepsy in the community – including family members, friends and professional carers – receive support, training and guidance in the administration of buccal midazolam. This article provides an overview of the treatment of SE in the community, including the administration of buccal midazolam.